Given the strong evidence of the association between tumour infiltrating CD8 T-cells with responsiveness to immunotherapies [45,46], we wanted to further explore, in a larger cohort of patients, whether CD8 T-cells were depleted in tumours with EGFR oncogenic mutations. This evidence concerns the gene CD8A and neoplasm.